Human Gene Therapy Trial of Kidney Cancer Vaccine
Johns Hopkins MedicineResearchers at the Johns Hopkins Oncology Center and the Department of Urology have confirmed successful activation of patients' immune systems in one of the first human trials of a genetically engineered cancer vaccine. Their findings, reported in the April 15, 1997, issue of Cancer Research, are the result of more than eight years of laboratory, animal and preclinical human studies.